Arralis appears on Hong Kong-based consortium’s radar

Enterprise Ireland is among a group of investors exiting as part of the round, which will add up to 25 new jobs.

Arralis has secured €50m ($53m) in funding from a consortium of Hong Kong-based investors, according to the Irish Times.

The company, established in 2013 and based at Limerick University, is a developer of radar, geolocation and wireless communication technologies for aerospace, defence and communications companies. It currently employs 20 people.

The investment will enable the company to create 25 new jobs and mass produce its components. Arralis will additionally set up a supply chain in Hong Kong, which will give it the ability to secure bigger sales.

Previous investors, including Enterprise Ireland, the export credit agency of the Irish government, Kernel Capital and ACT have exited as part of this round. The identity of the new investors has not been made public.

Enterprise Ireland, Kernel Capital, ACT and Qubis supplied $1.6m in funding in 2014, according to deals database PitchBook.

Barry Lunn, chief executive of Arralis said: “It was inevitable from day one that we would hit a stage when we would need this level of investment, due to the type of product we do.

“There is always money if you have the right product and the right market.”


See more from this Government Report: Ireland


Copyright Mawsonia Limited 2010. Please don't cut articles from or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. STT reinforces Armor with $89m investment

    April 06, 2017

  2. UK to review tax breaks

    April 03, 2017

  3. BDC helps accelerate Calgary startups

    April 13, 2017

  4. Arralis appears on Hong Kong-based consortium’s radar

    April 05, 2017

  5. Tianjin City launches $17.4bn fund

    April 13, 2017


  • 23 May - 24 May, 2017

    GCV Symposium 2017 - London

    Join 400+ business leaders from the corporate venturing and wider high growth business ecosystem for the two-day 2017 GCV Symposium.

  • More Events